Masonic Cancer Center of the University of Minnesota
Public and Patients
- About Us
- Cancer Information
- Clinical Trials
- Events & Outreach
- Make a Gift
- News & Feature Stories
- Survivorship
Researchers and Staff
BMT Conferences
Held every Monday
1:15-2:15 p.m.
Room 450, Cancer Center Research Building
| DATE | TOPIC | SPEAKER |
|---|---|---|
| 09/11/06 | No BMT conference | Cancer Center President's Cancer Panel |
| 09/18/06 | Attending meeting | |
| 09/25/06 | Program meeting | |
| 10/02/06 | Microbial contamination of hematopoietic stem cell products: Incidence and clinical sequelae | Linda Burns, M.D. Associate Professor Division of Hematology, Oncology and Transplantation |
| 10/09/06 | Umbilical cord blood transplantation: Contribution of HLA matching and cell dose | John E. Wagner, Jr., M.D . Director, Pediatric Hematology/Oncology and Blood and Marrow Transplant Program Professor, Department of Pediatrics Scientific Director of Clinical Research, University of Minnesota Blood and Marrow Transplant Program and Stem Cell Institute Director, Center for Molecular and Cellular Therapy |
| 10/16/06 | Total marrow irradiation using tomotherapy in stem cell transplantation: theoretical aspects and experience to date | Susanta K Hui, Ph.D. Assistant Professor Department of Therapeutic Radiology Kathryn E. Dusenbery, M.D. Associate Professor and Chair Department of Therapeutic Radiology Michael R. Verneris, M.D. Assistant Professor Pediatric Hematology/Oncology and Blood and Marrow Transplant |
| 10/23/06 | Iron Overload Following HCT | Navneet Majhail, M.D., Fellow, Division of Hematology, Oncology and Transplantation |
| Randomized Phase II Study of Zoledronic Acid in the Prevention of Osteoporsis
Bexxar BEAM for NHL |
Linda Burns, M.D., Associate Professor, Division of Hematology, Oncology and Transplantation | |
| A Phase II Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation | Margaret MacMillan, M.D., Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology and Blood and Marrow Transplantation | |
| What does CSA do to NK Cells? | Michael Verneris, M.D., Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology and Blood and Marrow Transplantation | |
| Nonmyeloablative UCB Transplantation Myeloablative UCB Transplantation | Claudio Brunstein, M.D., Ph.D., Assistant Professor, Department of Medicine, Division of HOT | |
| GVHD Studies | Daniel Weisdorf, M.D., Professor of Medicine Director, Adult Blood & Marrow Transplant Program -and- Mukta Arora, M.D., Assistant Professor, Department of Medicine, Division of HOT |
|
| 10/30/06 | Dyskeratosis congenita: an under-recognized cause of bone marrow failure | Blanche P. Alter, M.D., M..PH., Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services |
| 11/06/06 | Potential new radioprotective agents | Angela Panoskaltsis-Mortari, Ph.D., D(ABMLI) Associate Professor Department of Pediatrics, Hematology/Oncology and Blood and Marrow Transplantation Pulmonary and Critical Care Medicine University of Minnesota |
| 11/13/06 | Maribavir: a new CMV antiviral agent | Jo-Anne van Burik, M.D. Associate Professor Departments of Medicine and Infectious Disease University of Minnesota |
| 11/20/06 | Attending meeting | |
11/27/06 ASH Presentations |
Notch activation in cord blood progenitors induces a CD7+ common NK/T precursor capable of NK cell commitment without full maturation and differentiation of lineage committed pre-T lymphocytes with a Th 1 phenotype | Veronika Bachanova, M.D. Division, HOT |
| Characterization of hematopoietic progenitor cells derived from human embryonic stem cells that differentiate into natural killer cells capable of in vivo anti-tumor activity | Petter Woll Graduate Research Assistant Division, HOT |
|
| Single versus double umbilical cord blood transplantation (UCBT): Higher risk of acute graft versus host disease (GVHD) but lower transplant related mortality (TRM) in recipients of double UCBT | Margaret MacMillan, M.D. Division, Pediatric H/O/BMT |
|
| Toll-like receptor 7-targeting of human B-lineage acute lymphocytic leukemia induces immunogeneicity and apoptosis of leukemia cells | Xueqing Liang Research Associate Division, Pediatric H/O/BMT |
|
| Sleeping beauty (SB) transposon mediated umbilical cord blood (UCB) T cell therapy for refractory acute lymphoblastic leukemia (ALL) | Xianzheng Zhou, M.D., Ph.D. Division, Pediatric H/O/BMT |
|
12/04/06 ASH Presentations |
Umbilical cord blood transplant after reduced intensity conditioning provides outcomes comparable HLA-matched siblings for patients with high risk and advanced acute myeloid leukemia | Claudio Brunstein, M.D., Ph.D. Division, HOT |
- Lymphodepletion followed by donor lymphocyte infusions (DLI) causes significantly more acute graft versus host disease than DLI alone - KIR ligand absence in recipients of unreleased donor (URD) Allogeneic hematopoietic cell transplantation (HCT) is associated with less relapse and increased graft versus host disease (GVHD) |
Jeffrey Miller, M.D. Division, HOT |
|
| Unrelated donor hematopoietic cell transplant (HCT) for hemophagocytic lymphohistiocytosis (HLH) | K. Scott Baker, M.D., M.S. Division, Pediatric H/O/BMT |
|
| Induction of endogenous repair mechanisms by single-stranded DNA oligonucleotide therapy for correction of the DNA-PK mutation in murine severe combined immune deficiency | Jakub Tolar, M.D., Ph.D. Division, Pediatric H/O/BMT |
|
| 12/11/06 | No conference due to ASH | |
| 12/18/06 | Thinking outside the dish | Jakub Tolar, M.D., Ph.D. Assistant Professor Department of Pediatrics Pediatric Hematology/Oncology and Blood and Marrow Transplantation |
| 12/25/06 | No conference due to holiday | |
| 01/01/07 | No conference due to holiday | |
| 01/08/07 | New developments in vaccinology | Jo-Anne van Burik, M.D. Associate Professor Department of Medcine, Division of Infectious Diseases and International Medicine University of Minnesota |
| 01/15/07 | No conference due to Martin Luther King holiday | |
| 01/22/07 | Non-myeloablative sibling donor transplants | Marcie Tomblyn, M.D. Assistant Professor of Medicine Division of Hematology/Oncology and Transplantation University of Minnesota |
| 01/29/07 | Program meeting | |
| 02/05/07 | Thymic shielding in recipients of TBI and alternative donor HSCT: Reduced risk of opportunistic infection in patients with FA | Margaret MacMillan, M.D. Assistant Professor Department of Pediatrics Pediatric Hematology/Oncology and Blood and Marrow Transplantation |
| 02/12/07 | No conference due to Tandem meetings | |
| 02/19/07 | Transplantation for the older patient with AML and MDS | Betul Oran, M.D. Hosted by: Daniel Weisdorf, M.D |
| 02/26/07 | Metabolic syndrome and cardiovascular risk factors in survivors after HCT | Scott Baker, M.D., MS Associate Professor Department of Pediatrics Pediatric Hematology/Oncology and Blood and Marrow Transplantation |
| 03/05/07 | Mukta Arora, M.D. Assistant Professor Department of Medicine Division of HOT University of Minnesota |
|
| 03/12/07 | High dose granulocyte transfusion therapy for the treatment of infection in neutropenia | Jo-Anne van Burik, M.D. Associate Professor Departments of Medicine and Infectious Disease -and- Jeffrey McCullough, M.D. Professor Lab Medicine and Pathology University of Minnesota |
| 03/19/07 | Leukodystrophies: clinical, biochemical and genomic studies | Paul Orchard, M.D. Associate Professor Department of Pediatrics Pediatric Hematology/Oncology and Blood and Marrow Transplantation University of Minnesota |
| 03/26/07 | Attending meeting | |
| 04/02/07 | Update of allogeneic NK cell therapies: from lab to clinic | Sarah Cooley, M.D. Assistant Professor Department of Medicine Division of HOT University of Minnesota |
| 04/09/07 | Umbilical cord blood | Claudio Brunstein, M.D. Assistant Professor Department of Medicine, Division of HOT University of Minnesota |
| 04/16/07 | Transposon-mediated T-cell therapy for leukemia: from bench to bedside | Xianzheng Zhou, M.D., Ph.D. Assistant Professor Pediatric Blood and Marrow Transplantation University of Minnesota |
| 04/23/07 | Results of mycophenolate pharmacokinetic and busulfan pharmacogenetic studies | Pamala Jacobson, Pharm D. Associate Professor Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota |
| 04/30/07 | Immune globulins in clinical use | Jo-Anne van Burik, M.D. Associate Professor Departments of Medicine and Infectious Disease University of Minnesota |
| 05/07/07 | Mechanisms underlying dendritic Ccell-induced CD4 Treg generation | Wei Chen, M.D., Ph.D. Associate Professor Department of Pediatrics Pediatric Hematology/ Oncology and Blood and Marrow Transplantation University of Minnesota |
| 05/14/07 | What is new in anti-tumor therapies from human ES cells? | Daniel Kaufman, M.D., Ph.D. Assistant Professor Stem Cell Institute Department of Medicine University of Minnesota |
| 05/21/07 | CD4+25+ T regulatory cells (Tregs) using cell-based artificial antigen-presenting cells (aAPCs) | Keli Hippen, Ph.D. Assistant Professor Department of Pediatrics Pediatric Hematology/ Oncology and Blood and Marrow Transplantation University of Minnesota |
| 05/28/07 | Canceled due to holiday |
2005-2006 Conferences
2004-2005 Conferences
2003-2004 Conferences
Click to go to the Cancer Progression and Metastasis Program